To compare the effect of alcohol-free Mediterranean-type diet (MD) and high-fat diet (HFD) on plasma concentration of emergent haemostatic cardiovascular risk factors (HCVRF). Also, to test if red wine supplementation modi®es HCVRF, independent of diet. Design, subjects and intervention: Controlled prospective intervention study. Two groups, each of 21 healthy male university students (22 AE 3.4 y), received either MD or HFD for 90 days. Between days 30 and 60, both diets were supplemented with 240 mladay of red wine. Baseline and T30, T60 and T90-day samples were drawn. No drop out from the study was observed. Setting: University campus and outpatient nutrition clinic. Results: Volunteers on HFD at T30 had increases in pro-coagulants ®brinogen (22%), factor VIIc (9%), and factor VIIIc (4%), and decreases in natural anticoagulants antithrombin III (3%), protein C (11%) and protein S (6%) and of 20% in plasminogen activator inhibitor-1. At the same time, individuals on MD had increases in ®brinogen (4%), antithrombin III (5%), protein C (3%), protein S (2.7%), and decreases in factor VIIIc (9%), and plasminogen activator inhibitor-1 (21%). After adjusting by baseline values, MD was associated with lower plasma ®brinogen (P 0.03), factor VIIc (P 0.034) and factor VIIIc (P 0.0057) and with higher levels of protein S (P 0.013). Red wine supplementation, in both diets, resulted in decreased plasma ®brinogen (P 0.001) and factor VIIc (P 0.05), and increased tissue plasminogen activator antigen (P 0.01) and plasminogen activator inhibitor-1 antigen (P 0.0003). Wine consumption was also associated with signi®cantly (P 0.01) divergent effects on antithrombin III: it decreased by 10% in individuals on HFD but increased slightly in those on MD. No effects of diet or wine were detected in plasma protein C and C-reactive protein.
Introduction
Intervention and epidemiological studies show that some dietary habits and light-to-moderate alcohol consumption provide cardiovascular (CV) protection. A recent publication summarized these effects, indicating that foods of animal origin are directly correlated whereas vegetablefood groups, ®sh and alcohol are inversely correlated with coronary heart disease mortality (Menotti et al, 1999) . Populations consuming a diet rich in vegetables, olive oil, ®sh and wine (Mediterranean diet, MD) had the lowest mortality among the seven countries included in that study. The bene®ts of this diet apparently can be transferred to populations of other ethnic origins (Kouris-Blazos et al, 1999) and have also been reproduced in secondary prevention trials (de Lorgeril et al, 1999) .
Alcoholic beverages, mostly wine, are a constitutive component of MD. Whether wine itself adds an independent CV bene®t to this diet is a matter of debate (de Lorgeril & Salen, 1999) . Despite reports indicating that light to moderate alcohol consumption reduces CV mortality (Thun et al, 1997) and stroke (Berger et al, 1999) , wine drinking has also been related with the intake of healthier diets (Tjonneland et al, 1999) , and with other advantageous lifestyle characteristics (Wannamethee & Shaper, 1999) . Thus, the proposal of Renaud et al that alcohol, speci®cally wine, is a major determinant of the bene®ts of MD (Renaud & de Lorgeril, 1992) needs to be demonstrated.
Lower rates of CV disease and mortality in Southern European countries could be only partially explained by differences in fat intake or in blood lipid pro®les (Kromhaut, 1999) . Accordingly, additional mechanisms, like changes in plasma levels of haemostatic factors, should contribute to this protection. Some of these factors have emerged as predictors for coronary heart disease (Ridker, 1997) , furthermore, several reports indicate that these are modi®able by diet and alcohol (including wine). In fact, MD on the whole (Bijnen et al, 1996) or distinctive components of this diet, such as lower saturated fat consumption, as well as higher intakes of monounsaturated fatty acids, fruit and vegetables, (Westrate et al, 1998; Roche et al, 1998; Temme et al 1999; Mezzano et al, 1999) appears related to a more favorable pro®le of haemostatic cardiovascular risk factors (HCVRF). The same holds for alcohol or wine, as summarized in a recent meta-analysis which revealed that CV bene®ts of alcohol intake are mostly mediated through changes in blood lipids and HCVRF, mainly ®brinogen (Rimm et al, 1999) .
The aims of the current study were two-fold: ®rst, to compare the effects of two alcohol-free diets, an MD and a high-fat, Western-type diet (HFD) on HCVRF; second, to assess the changes in these factors after supplementing each diet with a moderate amount of red wine.
Subjects and methods

Subjects and study design
The subjects of this intervention study were 42 healthy undergraduate or graduate university male students aged 22 AE 3.4 y, who gave informed consent to participate. Incorporation criteria included absence of clinical disease and obesity, serum lipids and glucose within the normal range, normal blood pressure and absent or mild alcohol drinking habit. All the participants were physically active, non-smokers, and received no medication or vitamin supplementation. The experimental protocol was approved by the Medical Ethics Committee of our institution. All the participants were interviewed and the average of three 24 h dietary recalls (two on week days and one on weekends) was used to estimate basal daily consumption of different nutrients and alcoholic beverages. A diagram with the intervention study design is shown in Figure 1 . For 90 days, 21 volunteers received an MD (Ferro-Luzzi & Branca, 1995) and the remaining 21 a high-fat, Westerntype (Browner et al, 1991) diet. From days 31 to 60 both diets were isocalorically supplemented with 240 mladay of red wine (cabernet sauvignon), providing 23.2 g of ethanoladay. No other alcoholic beverages were allowed during the 3 months of the study. Thirty students were randomly allocated to receive either MD or HFD. The remaining 12 were allowed to select the diet according to their 
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preferences in order to preserve their compliance with the study protocol. Measurements of haemostatic and selected nutritional variables were performed on fasting blood samples drawn around 8:00 am on baseline and on days 30, 60 and 90, along with clinical assessment of each participant. Volunteers declared that they would comply with the recommendations and none of them left the study.
Diets
Diets, prepared by a catering company, were daily supervised by one of the authors (OC). They were delivered at the campus at midday or at home at night and weekends, in personalized boxes. Speci®c indications for breakfast and snacks were provided to all the volunteers in concordance with each diet. Both diets were designed to provide the same caloric intake, with a daily average of 8168 kJaday (2565 kcaladay). Proteins supplied 17.6% of total calories for each diet. Fats supplied 27.3% and 39.9% of calories for MD and HFD, respectively. Mean contents of saturated, monounsaturated, polyunsaturated and o-3 fatty acids provided by MD and HFD were 22.7 vs 35.8 gaday, 37.9 vs 35.5 gaday, 9.6 vs 32.0 gaday, and 1.64 vs 0.96 ga day, respectively. Individuals on MD consumed an average of 32 mladay of olive oil. Fruit and vegetable consumption was, on the average, 675 gaday in MD and 246 gaday in HFD. White meat, ®sh and legumes were the main source of proteins in MD, whereas HFD was rich in red meat and low in ®sh. Diet composition was calculated employing the Food Processor II computer program (Esha Research, Salem, OR). More details on diet composition have been reported (Cuevas et al, 2000) . Lean weight was calculated by bioelectrical impedance analysis.
Laboratory methods
Plasma ®brinogen was measured by Clauss assay (FibriPrest 2, Diagnostica Stago, Asnie Áres-sur-Seine, France). Factor VIIIc was measured by one-stage, modi®ed APTT assay, and coagulant activity of factor VII (VIIc) by modi®ed prothrombin time using substrate de®cient plasma (Baxter Dade, FL, USA). Antithrombin III (AT III Ag), proteins C (protein C Ag) and S (Protein S Ag) and tissue plasminogen activator antigen (tPA Ag) in plasma were measured by immunoassays (Enzyme Research Labs, IN, USA). Plasminogen activator inhibitor antigen (PAI-1 Ag) was measured by ELISA (Chromogenix, Sweden). All these assays were performed as previously described (Mezzano et al, 1999) . C-reactive protein (CRP) was determined by competitive immunoassay (Macy et al, 1997) with minor modi®cations and with a sensitivity of 0.18 mgal (Mezzano et al, 1999) . Serum folate and vitamin B 12 were determined by ion capture and microparticle immunoassays, respectively (IMX 1 Folate and AxSYM B 12 , Abbott Labs, IL, USA) and vitamin C by a procedure based in reduction of ferric chloride, as described (Cuevas et al, 2000) . Eicosapentaenoic content in plasma lipids was determined by gas chromatography (Christie, 1989) and expressed as percentage of total fatty acids. Plasma atocopherol and lycopene were measured by HPLC with electrochemical detection (Motchnik et al, 1994) . To control for interassay variation, care was taken to measure always in the same run the four samples of one individual on MD along with the samples of one subject on HFD.
Statistical analysis
Two-tailed, unpaired Student's t-test or Mann ± Whitney test were used to compare the means of different variables between MD and HFD groups at baseline. Proportions were compared by two-tailed, Fisher's exact test. A linear mixed effects model (repeated measure ANOVA) (Verbeke & Molenberghs, 1997 ) was used to compare both diets and the effect of wine on haemostatic factors during the study period at 30, 60 and 90 days. To correct for small group differences explained by between subject variability and to adjust for lack of absolute randomization, the values at 30, 60 and 90 days were controlled by the baseline measurement, which was used in the model as a covariate. An ANOVA-type F-statistic was calculated to test the effect of diet (MD vs HFD) across the study time (30, 60 and 90 days), controlling by the initial values. The effect of wine, combining the two dietary groups, was evaluated comparing response of all subjects at 60 days vs the average of values at 30 and 90 days using an F-statistic based on within-subject source of variability. Also, to control a longer than expected wine effect, the response at 60 days vs values at 30 days were compared. Finally, the wine effect was also tested for each dietary group independently, despite loss of statistical power. Normal distribution was checked on the residuals of all factors considered in this work. In those cases where a departure of the normality assumption was detected a similar analysis was performed using the rank statistics instead of the raw data, as a nonparametric alternative of the same analysis. The proc MIXED of the SAS statistical program was used for these purposes.
Results
Analysis of dietary recalls before the start of the intervention study disclosed no signi®cant mean differences in intake of several nutrients between MD and HFD groups (data not shown). Alcohol consumption, mostly beer and spirits, averaged less than 1.5 drinksaweek in both study groups. Some anthropometric, hematologic and nutritional measurements at baseline (day 0) are shown in Table 1 . The small differences in mean values observed between individuals assigned to MD or HFD groups were not signi®cantly different. After 30 days of intervention, individuals on MD had signi®cantly higher levels of plasma b-carotene Dietary and wine intervention did not result in signi®-cant changes in total plasma cholesterol in both study groups, at any time, as shown in Figure 2 . This was also observed for LDL and HDL-cholesterol, and for serum triacylglycerol (data not shown).
Effects of diet on HCVRF (Table 2)
Despite lack of absolute randomization, no signi®cant differences were observed in plasma concentration of HCVRF at T0 (baseline) between groups on MD and HFD. CRP was measured at all times in all volunteers to control for in¯ammatory changes within individuals and within groups, and the results are also included in Table 2 . As shown, no signi®cant baseline differences, nor changes induced by diet or wine in this in¯ammatory marker were observed.
Volunteers on HFD at T30 had increases in pro-coagulants factors ®brinogen (22%), FVIIc (9%), and FVIIIc (4%), and decreases in natural anticoagulants antithrombin III (3%), protein C (11%) and protein S (6%) and of 20% in plasminogen activator inhibitor-1. At the same time, individuals on MD had increases in ®brinogen (4%), antithrombin III (5%), protein C (3%), protein S (2.7%), and decreases in factor VIlIc (9%) and plasminogen activator inhibitor-1 (21%). After controlling by baseline values, the effect of diet across the study time (T30, T60, T90), showed that group on MD had lower mean plasma ®brino-gen (P 0.03), factor VIIc (P 0.034) and factor VIlIc (P 0.0057), and higher levels of protein S (P 0.013) than the group on HFD. Plasma concentration of factor VIIIc was controlled by ABO blood type of volunteers in both dietary groups. A higher, though not statistically signi®cant, proportion of individuals of blood type O belonged to the HFD group (11a21) as compared to that of MD (5a21; P 0.11). No signi®cant differences between dietary groups were detected in plasma levels of anticoagulant proteins C and ATIII, nor in ®brinolytic system components tPA:Ag and PAI-1Ag.
Effects of wine on HCVRF (Table 2)
The effect of wine was evaluated combining the results of both dietary groups and comparing the response of all the subjects at T60 vs T30 and at T60 vs (T30 T90)a2. In both cases, red wine consumption was associated with reduction in plasma ®brinogen (P 0.001 and P 0.0005, respectively). This effect was greater in subjects on HFD, where ®brinogen decreased to almost equal level to that of subjects on MD at the end of wine intake. In fact, the effect of wine was also statistically signi®cant for HFD group (n 21) when analysed independently (P 0.008 and 0.006, for both methods of calculation). Intake of wine resulted in reduction of factor VIIc in plasma, when comparing T60 vs T30 or (T30 T90)a2 vs T60 (P 0.05), whereas no signi®cant effect of wine was detected for factor VIIIc.
Plasma concentration of the ®brinolytic system proteins tPA:Ag and PAI-1 Ag increased signi®cantly after 1 month of red wine consumption. For tPA:Ag, the observed signi®cance levels were P 0.0004 (comparison of T30 vs T60) and P 0.01 ((T30 T90)a2 vs T60). Similar comparisons for PAI-1 Ag resulted in P-values of 0.0003 and 0.0001, respectively. The effect of wine was also statistically signi®cant for PAI-1 Ag in both dietary groups when analysed independently.
Wine consumption had divergent effects on AT III Ag depending on diet: it increased slightly, though not signi®c-antly, in individuals on MD but decreased in those on HFD; Figure 2 Comparative effect of Mediterranean diet (MD) and high-fat diet (HFD), and effect of red wine on total serum cholesterol. Volunteers received red wine from days 30 to 60. The observed differences between diets and after wine intake were not signi®cantly different.
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P 0.03, (comparison of T30 vs T60) and P 0.022 ((T30 T90)a2 vs T60). This contrasting effect resulted in a statistically signi®cant difference in AT III Ag levels between both diets at T60 (P 0.01). Wine consumption had no signi®cant effects on plasma levels of proteins C and S.
Discussion
This prospective intervention study was performed in homogeneous cohorts of young, healthy, physically active male students, without known diseases and CV risk factors, namely, dyslipidemia, smoking, fasting hyperglycemia, high blood pressure and obesity. No signi®cant differences in previous nutrient intake between MD and HFD groups was detected in a dietary recall performed at T0. Similarly, no statistical differences were observed in anthropometric, haematological or plasma analytes. As expected, signi®cant changes in speci®c biochemical measurements dependent on the different nutrient intake provided by each diet were observed 1 month after the start of the study. With regard to HCVRF, changes in plasma levels of several haemostatic factors were detected in relation to diet and wine intake. Brie¯y, MD was associated with lower plasma ®brinogen, F VIIc and F VIIIc and with higher levels of protein S. Wine supplementation in both diets resulted in decreases in plasma ®brinogen and F VIIc, and in increases in tPA-Ag and PAI-1 Ag. Moreover, wine intake was associated with AT III decrease in individuals on HFD but with slight increase in those on MD. No effects of diet or wine were detected in plasma protein C. Measurement of CRP, an acute-phase reactant, allowed a better control and interpretation of changes in haemostatic CV risk factors which are also acute-phase proteins (ie ®brinogen), or behave as in¯ammation-sensitive proteins (ie factor VIIIc). Plasma CRP level, which is also a CV risk factor (Ridker, 1997) , did not change either with diet or wine intervention.
Plasma levels of ®brinogen and, probably those of factors VIIc and VIIIc, have direct association with CV disease (Ridker, 1997; Mead et al, 1986; Held et al, 2000; Rumley et al, 1999; Iacoviello et al, 1998; Redondo et al, 1999) . It has been hypothesized that differences in diet and wine intake could partially explain the lower CV morbidity and mortality in southern European countries in comparison with their northern counterparts. In support of this, populations of Italy, who consume mainly a Mediterraneantype diet, but who also have additional lifestyle differences and drink more alcohol, have lower plasma ®brinogen and factor VIIc than Dutch populations (Bijnen et al, 1996) . A similar, diet-related variation for F VIIIc had not yet been described.
With regard to ®brinogen, we found an effect of diet, independent of wine, with lower levels in subjects on MD. Moreover, a signi®cant reduction of plasma ®brinogen was observed after 30 days of moderate red wine consumption. Decrease in ®brinogen concentration was not accompanied with a parallel change in CRP, denoting lack of relation with an in¯ammatory reaction. A high plasma ®brinogen c Effect of wine was evaluated combining both groups (MD and HFD) and comparing their response at T60 vs (T30 T90)a2 as well as T60 vs T30. The P-value shown is the less signi®cant of both calculations. d Denotes statistically signi®cant effect of wine in an individual dietary group. Effect of HFD-wine on ®brinogen (P 0.008); of MD-wine on FVIIc (P 0.05); of MD-wine on PAI-1Ag (P 0.03); of HFD-wine on PAI-1Ag (P 0.005); of HFD-wine on ATIII (P 0.03).
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level has been proposed as a causal risk factor and a possible link between alcohol consumption and reduced risk of CV disease (Mennen et al, 1999) . In this context, our ®ndings con®rm previous evidence indicating that light to moderate alcohol intake is associated with lower ®brino-gen levels, as recently summarized in a meta-analysis (Rimm et al, 1999) . Furthermore, they support the notion that differences in ®brinogen levels in populations of diverse ethnic origins (Bijnen et al, 1996) may be determined by acquired factors (ie type of diet and level of alcohol intake). Even though the previously referred association of high levels of factor VIIc and CV risk has been recently disputed (Feng et al, 2000; Doggen et al, 1998; Ghaddar et al, 1998) both MD and red wine intake were associated with decrease in its plasma concentration. This observation agrees with a previous population study (Bijnen et al, 1996) and, furthermore, it con®rms that factor VIIc levels are not only genetically determined, but are also affected by environmental factors (Ghaddar et al, 1998; Larsen et al, 1997; Ishikawa et al, 1997) . Recently, Dimmitt et al found a 7% increase in factor VII after 4 weeks of 58 ml of daily alcohol intake in beer (Dimmitt et al, 1998) . The discrepancy with our results could be explained either by the much higher dose of alcohol or the different type of alcoholic beverage.
High plasma factor VIIIc has been associated with increased CV risk (Rumley et al, 1999; Tracy et al, 1999) . We found that volunteers on HFD had signi®cantly higher factor VIII activity than individuals on MD, but red wine intake had no effect on this variable. Both genetic and environmental conditions determine plasma levels of this protein. First, factor VIIIc in plasma is lower in individuals of blood type O than in those with blood types A, B and AB (Gill et al, 1987) . This is not the explanation for our ®ndings, since only 24% of volunteers on MD had blood type O, whereas 52% of those on HFD were of this blood type. Accordingly, if the proportions of blood types between dietary groups had been similar, the difference in factor VIIIc probably would have been larger. Second, factor VIIIc is an in¯ammation-sensitive protein, whose concentration raises in parallel with other acute-phase proteins. In this context, no signi®cant changes in CRP were observed, suggesting that the difference in factor VIIIc levels attributed to diet is independent of an in¯ammatory reaction.
In the Physicians Health Study, a positive association between moderate alcohol intake and plasma levels of endogenous tPA Ag was found . Similarly, a short-term alcohol intake (Hendriks et al, 1994; Johansen et al, 1999) or consumption for longer periods (Dimmitt et al, 1998) , also increased plasma tPA Ag in healthy subjects. Our data are consistent with those ®ndings, which were interpreted as potentially bene®cial in the context of CV risk. However, they are in con¯ict with those of Pellegrini et al (1996) , who found a non-signi®cant increase in tPA Ag after a 4 week supplementation of daily diet with 320 ml of red wine. Inspection of data of both studies suggests that this discrepancy can be better explained by the larger number of observations in our work than by methodological issues or differences in absolute tPA values. We also found that plasma PAI-1 Ag does not depend on type of diet; however, red wine signi®cantly increased its plasma concentration, con®rming previous reports (Dimmitt et al, 1998; Johansen et al, 1999) . It is paradoxical that elevated tPA antigen levels can identify subjects at risk for future myocardial infarction (Ridker et al, 1993) or stroke, since tPA has an antithrombotic potential by enhancing ®brin removal. Conversely, the notion that increase in PAI-1, which complexes and inactivates tPA, is a predictor of CV risk (Ridker, 1997) has been recently disputed (Doggen et al, 1999; Anderson et al, 1999) . Our study did not address the issue of the effect of moderate wine intake on in vivo ®brinolysis, as we did not measure the effects of the simultaneous increases in tPA Ag and PAI-1 Ag on the functional ®brinolytic balance. In this regard Johansen et al (1999) , recently showed that a single intake of red wine in the evening had no signi®cant effect on whole blood clot lysis time in samples drawn the next morning.
Natural anticoagulants AT III and proteins C and S inhibit thrombin generation and ®brin deposition. Their role in the prevention of venous thromboembolism is well established, but their antithrombotic potential in arterial disease is less clear. Recent studies suggest that frequent gene polymorphisms (factor V Leiden and prothrombin variant G20210A), which are associated with venous thrombosis, have synergistic effects with atherogenic factors and increase the risk of myocardial infarction Inbal et al, 1999) . Protein S de®ciency may play a role in arterial thrombosis and potentiates other acquired or hereditary risk factors (Callas et al, 1998; Zoller et al, 1998) and patients with protein C de®ciency appear to have increased risk for earlier myocardial infarction (Sakata et al, 1999) . Accordingly, the higher values of protein S in individuals on MD could be protective for CV risk. The divergent effects of red wine on AT III levels depending on type of diet were unexpected, and the changes may represent an additional disadvantage of HFD: after one month with red wine, a decline of 10% of AT III Ag levels was observed in individuals on this diet, whereas a protection against this loss was apparent in volunteers on MD. A previous population study had shown an inverse association between alcohol intake and AT III levels, but this association was more evident in individuals with higher amounts of ethanol consumption than in our study (Bijnen et al, 1996) .
The potential antithrombotic advantage of consuming a Mediterranean-type of diet associated with a moderate amount of red wine has no straightforward biological explanation. Even though a balanced ratio of o-6ao-3 essential fatty acids and abundance of antioxidant compounds may have a mild anti-in¯ammatory effect (de Lorgeril & Salen, 2000) , the lack of signi®cant differences in plasma levels of CRP protein between both diets does Effects of Mediterranean diet D Mezzano et al not support this interpretation. The possibility that a decreased oxidative injury derived from MD and red wine consumption (Visioli, 2000) modulates the coagulation system deserves a systematic evaluation.
From the point of view of HCVRF, this study con®rmed the overall health advantage of a diet with less total and saturated fat and red meat, but richer in monounsaturated fatty acids, white meat, ®sh, fruit and vegetables. It also revealed that the addition of a moderate amount of red wine further improves the haemostatic pro®le of this type of diet, as well as that of individuals with higher fat diets. We tested the effect of red wine because it constitutes the major alcoholic beverage consumed with MD. As previously discussed, some of the effects observed in our study have also been attributed to ethanol contained in other alcoholic beverages. It remains to be established what the relative contributions are of alcohol and other constituents of red wine, such as polyphenols, in the improved CV risk factor pro®le associated with moderate red wine intake.
